4. Roberts KA, Colley L, Agbaedeng TA, Ellison-Hughes GM, Ross MD. Vascular Manifestations of COVID-19 – Thromboembolism and Microvascular...
5. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022; 28(3):583-90.
6. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin....
7. Félix NDC, Nóbrega MML. Metabolic Syndrome: conceptual analysis in the nursing context. Rev. Latino-Am. Enfermagem. 2019;27:e3154.
8. Mechanick JI, Rosenson RS, Pinney SP, Mancini DM, Narula J, Fuster V. Coronavirus and Cardiometabolic Syndrome. J. Am. Coll. Cardiol. 2020;...
9. Norris T, Razieh C, Zaccardi F, Yates T, Islam N, Gillies CL, et al. Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal...
10. Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat. Rev. Endocrinol. 2021;...